Expanding indications for the Boston keratoprosthesis

Current Opinion in Ophthalmology

Volumn 22, Issue 4, 2011, Pages 267-273

  Colby, Kathryn A ^a   Koo, Euna B ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

artificial cornea; Boston keratoprosthesis; corneal blindness; corneal transplant

Indexed keywords

BEVACIZUMAB; IMMUNOMODULATING AGENT;

AMBLYOPIA; ANIRIDIA; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; BOSTON KERATOPROSTHESIS; CHORISTOMA; CORNEA DYSTROPHY; CORNEA INJURY; CORNEA OPACITY; CORNEA TRANSPLANTATION; CORNEA TUMOR; COST EFFECTIVENESS ANALYSIS; GLAUCOMA; GRAFT FAILURE; HERPES SIMPLEX KERATITIS; HUMAN; INTRAOCULAR PRESSURE; IRIDOCORNEAL ENDOTHELIAL SYNDROME; KERATOCONUS; KERATOPATHY; KERATOPROSTHESIS; MUCOUS MEMBRANE PEMPHIGOID; OUTCOME ASSESSMENT; PEDIATRIC SURGERY; PRIORITY JOURNAL; SCAR FORMATION; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; TREATMENT INDICATION; VISUAL ACUITY;

ARTIFICIAL ORGANS; CORNEA; CORNEAL DISEASES; CORNEAL TRANSPLANTATION; HUMANS; PROSTHESES AND IMPLANTS; TREATMENT OUTCOME;

EID: 79959209364     PISSN: 10408738     EISSN: 15317021     Source Type: Journal    
DOI: 10.1097/ICU.0b013e3283477d0d     Document Type: Article

References (42)

1. Aldave AJ, Kamal KM, Vo RC, et al. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology 2009; 116:640-651.
2. Klufas MA, Colby KA. The Boston keratoprosthesis. Int Ophthalmol Clin 2010; 50:161-175.
3. Chew HF, Ayres BD, Hammersmith KM, et al. Boston keratoprosthesis outcomes and complications. Cornea 2009; 28:989-996.
4. Gomaa A, Comyn O, Liu C. Keratoprostheses in clinical practice: a review. Clin Experiment Ophthalmol 2010; 38:211-224.
5. Traish AS, Chodosh J. Expanding application of the Boston type I keratoprosthesis due to advances in design and improved postoperative therapeutic strategies. Semin Ophthalmol 2010; 25:239-243.
6. Bradley JC, Hernandez EG, Schwab IR, et al. Boston type 1 keratoprosthesis: the university of california davis experience. Cornea 2009; 28:321-327.
7. Halberstadt M, Machens M, Gahlenbek KA, et al. The outcome of corneal grafting in patients with stromal keratitis of herpetic and nonherpetic origin. Br J Ophthalmol 2002; 86:646-652. (Pubitemid 34627955)
8. Todani A, Gupta P, Colby K. Type I Boston keratoprosthesis with cataract extraction and intraocular lens placement for visual rehabilitation of herpes zoster ophthalmicus: the KPro Triple. Br J Ophthalmol 2009; 93:119.
9. Pavan-Langston D, Dohlman CH. Boston keratoprosthesis treatment of herpes zoster neurotrophic keratopathy. Ophthalmology 2008; 115:S21-S23. (Pubitemid 351173973)
10. Khan BF, Harissi-Dagher M, Pavan-Langston D, et al. The Boston keratoprosthesis in herpetic keratitis. Arch Ophthalmol 2007; 125:745-749. (Pubitemid 46919734)
11. Birch EE, Cheng C, Stager DR, et al. The critical period for surgical treatment of dense congenital bilateral cataracts. J AAPOS 2009; 13:67-71.
12. Nallasamy S, Colby K. Keratoprosthesis: procedure of choice for corneal opacities in children? Semin Ophthalmol 2010; 25:244-248.
13. Huang C, OHara M, Mannis MJ. Primary pediatric keratoplasty: indications and outcomes. Cornea 2009; 28:1003-1008.
14. Dunlap K, Chak G, Aquavella JV, et al. Short-term visual outcomes of Boston type 1 keratoprosthesis implantation. Ophthalmology 2010; 117:687-692.
15. Aquavella JV, Gearinger MD, Akpek EK, et al. Pediatric keratoprosthesis. Ophthalmology 2007; 114:989-994. (Pubitemid 46635863)
16. Yaghouti F, Nouri M, Abad JC, et al. Keratoprosthesis: preoperative prognostic categories. Cornea 2001; 20:19-23. (Pubitemid 32038149)
17. Ciralsky J, Papaliodis GN, Foster CS, et al. Keratoprosthesis in autoimmune disease. Ocul Immunol Inflamm 2010; 18:275-280.
18. Ament JD, Spurr-Michaud SJ, Dohlman CH, et al. The Boston Keratoprosthesis: comparing corneal epithelial cell compatibility with titanium and PMMA. Cornea 2009; 28:808-811.
19. Dohlman C, Colby K, Belin M, et al. Titanium vs. PMMA backplates for Boston keratoprosthesis: incidence of retroprosthetic membrane. Invest Ophthalmol Vis Sci 2009; 50:ARVO E-Abstract 1505.
20. Pinar-Sueiro S, Etxebarria-Ecenarro J, Gibelalde A, et al. Successful Boston keratoprosthesis in a patient with Lyells syndrome. Arch Soc Esp Oftalmol 2009; 84:635-640.
21. Yildiz EH, Saad CG, Eagle R, et al. The Boston keratoprosthesis in 2 patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Cornea 2010; 29:354-356.
22. Lee H, Khan R, OKeefe M. Aniridia: current pathology and management. Acta Ophthalmol 2008; 86:708-715.
23. Akpek EK, Harissi-Dagher M, Petrarca R, et al. Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study. Am J Ophthalmol 2007; 144:227-231.
24. Harissi-Dagher M, Dohlman CH. The Boston keratoprosthesis in severe ocular trauma. Can J Ophthalmol 2008; 43:165-169. (Pubitemid 351518167)
25. Pineles SL, Ela-Dalman N, Rosenbaum AL, et al. Binocular visual function in patients with Boston type I keratoprostheses. Cornea 2010; 29:1397-1400.
26. Utine CA, Gehlbach PL, Zimmer-Galler I, et al. Permanent keratoprosthesis combined with pars plana vitrectomy and silicone oil injection for visual rehabilitation of chronic hypotony and corneal opacity. Cornea 2010; 29:1401-1405.
27. Ono K, Hiratsuka Y, Murakami A. Global inequality in eye health: country-level analysis from the Global Burden of Disease Study. Am J Public Health 2010; 100:1784-1788.
28. Ament JD, Todani A, Pineda R, et al. Global corneal blindness and the Boston keratoprosthesis type I. Am J Ophthalmol 2010; 149:537-539.
29. Zerbe BL, Belin MW, Ciolino JB, et al. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology 2006; 113:1779-1784.
30. Ament JD, Stryjewski TP, Ciolino JB, et al. Cost-effectiveness of the Boston keratoprosthesis. Am J Ophthalmol 2010; 149:221e2-228e2.
31. Ament JD, Tilahun Y, Mudawi E, et al. Role for ipsilateral autologous corneas as a carrier for the Boston keratoprosthesis: the Africa experience. Arch Ophthalmol 2010; 128:795-797.
32. Ciolino JB, Dohlman CH. Biologic keratoprosthesis materials. Int Ophthalmol Clin 2009; 49:1-9.
33. Dohlman J, Foster C, Dohlman C. Boston Keratoprosthesis in Stevens-Johnson Syndrome: a case of using infliximab to prevent tissue necrosis. Digital J Ophthalmol 2009; 15:5.
34. Rodrigues EB, Farah ME, Maia M, et al. Therapeutic monoclonal antibodies in ophthalmology. Prog Retin Eye Res 2009; 28:117-144.
35. Chak G, Aquavella JV. A safe Nd:YAG retroprosthetic membrane removal technique for keratoprosthesis. Cornea 2010; 29:1169-1172.
36. Stacy R, Jakobiec F, Michaud N, et al. Histopathological and immunohistochemical characterization of retro-keratoprosthesis membranes in the Boston type I keratoprosthesis. Arch Ophthalmol 2011; 129:310-316.
37. Ciolino JB, Hoare TR, Iwata NG, et al. A drug-eluting contact lens. Invest Ophthalmol Vis Sci 2009; 50:3346-3352.
38. Tay E, Utine CA, Akpek EK. Crescenteric amniotic membrane grafting in keratoprosthesis-associated corneal melt. Arch Ophthalmol 2010; 128:779-782.
39. Dohlman CH, Grosskreutz CL, Chen TC, et al. Shunts to divert aqueous humor to distant epithelialized cavities after keratoprosthesis surgery. J Glaucoma 2010; 19:111-115.
40. Rivier D, Paula JS, Kim E, et al. Glaucoma and keratoprosthesis surgery: role of adjunctive cyclophotocoagulation. J Glaucoma 2009; 18:321-324.
41. Rubin PA, Chang E, Bernardino CR, et al. Oculoplastic technique of connecting a glaucoma valve shunt to extraorbital locations in cases of severe glaucoma. Ophthal Plast Reconstr Surg 2004; 20:362-367. (Pubitemid 39281794)
42. Todani A, Fava M, Melki S, et al. Measurement of IOP with intraocular pressure transducer. Invest Ophthalmol Vis Sci 2009; 50:ARVO E-Abstract 5220.